Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30005555HIVENSG00000107537.14protein_codingPHYHNoNo5264O14832
TVIS20031613HPVENSG00000107537.14protein_codingPHYHNoNo5264O14832
TVIS20046083HPVENSG00000107537.14protein_codingPHYHNoNo5264O14832
TVIS20016393HPVENSG00000107537.14protein_codingPHYHNoNo5264O14832
TVIS20016394HPVENSG00000107537.14protein_codingPHYHNoNo5264O14832
TVIS20016268HPVENSG00000107537.14protein_codingPHYHNoNo5264O14832
TCGA Plot Options
Drug Information
GenePHYH
DrugBank IDDB00126
Drug NameAscorbic acid
Target IDBE0002117
UniProt IDO14832
Regulation Typecofactor
PubMed IDs11555634
CitationsMukherji M, Chien W, Kershaw NJ, Clifton IJ, Schofield CJ, Wierzbicki AS, Lloyd MD: Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease. Hum Mol Genet. 2001 Sep 1;10(18):1971-82. doi: 10.1093/hmg/10.18.1971.
GroupsApproved; Nutraceutical
Direct ClassificationButenolides
SMILES[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
PathwaysTyrosine Metabolism; Refsum Disease; The Oncogenic Action of Succinate; Disulfiram Action Pathway; Aromatic L-Aminoacid Decarboxylase Deficiency; Oxidation of Branched-Chain Fatty Acids; Catecholamine Biosynthesis; Monoamine Oxidase-A Deficiency (MAO-A); Tyrosinemia, Transient, of the Newborn; Carnitine Synthesis; Phytanic Acid Peroxisomal Oxidation; Hawkinsinuria; Dopamine beta-Hydroxylase Deficiency; Tyrosinemia Type I; Alkaptonuria; Tyrosine Hydroxylase Deficiency; The Oncogenic Action of Fumarate
PharmGKBPA451898
ChEMBLCHEMBL196